Related Experiment Video
Updated: Sep 18, 2025

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Cardiac Sympathetic Nerve Activity Is Not Elevated in Ovine Hypertensive HFpEF
Joshua W-H Chang1, Bindu George1, Mridula Pachen1
1Manaaki Manawa - The Centre for Heart Research, Department of Physiology, University of Auckland, New Zealand.
Cardiac sympathetic nerve activity is not elevated in heart failure with preserved ejection fraction (HFpEF). Beta-blockers worsen exercise hemodynamics in HFpEF, suggesting they should be avoided in these patients.
Area of Science:
- Cardiology
- Exercise Physiology
- Autonomic Nervous System
Background:
- Heart failure with preserved ejection fraction (HFpEF) is characterized by exercise intolerance.
- The role of sympathetic nervous system activity in HFpEF pathophysiology remains unclear.
- Evidence for heightened cardiac sympathetic nerve activity (CSNA) in HFpEF is lacking, potentially explaining the limited benefit of beta-blockers.
Purpose of the Study:
- To test the hypothesis that resting CSNA is not elevated in HFpEF.
- To investigate the impact of beta-blockers on exercise hemodynamics in HFpEF.
Main Methods:
- Utilized a conscious large animal (ovine) model of hypertensive HFpEF.
- Performed direct recordings of CSNA at rest.
- Assessed hemodynamic responses to graded treadmill exercise before and after beta-blocker administration.
Main Results:
- Resting CSNA levels were not elevated in the HFpEF ovine model.
- Beta-blocker administration impaired exercise hemodynamics, including cardiac output, heart rate, and pulmonary capillary wedge pressure, in HFpEF sheep.
- Differential exercise hemodynamic responses to beta-blockers were observed between HFpEF and non-HFpEF sheep.
Conclusions:
- CSNA is not elevated in this ovine model of hypertensive HFpEF.
- Favorable exercise hemodynamics in HFpEF appear to depend on beta-adrenergic activation.
- Findings suggest beta-blockers may be detrimental and should be avoided in HFpEF patients.
More Related Videos
11:08Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice.
Published on: February 14, 2018
10:08Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers